H. Lundbeck A/S- (HLUYY) Upgraded by Zacks Investment Research to “Strong-Buy”
H. Lundbeck A/S- (OTCMKTS:HLUYY) was upgraded by Zacks Investment Research from a “hold” rating to a “strong-buy” rating in a research report issued to clients and investors on Saturday. The firm presently has a $58.00 target price on the stock. Zacks Investment Research‘s price target would suggest a potential upside of 11.57% from the company’s current price.
According to Zacks, “H. Lundbeck A/S is an international pharmaceutical company engaged in the research and development, production, marketing and sale of pharmaceuticals across the world. Its products are targeted at disorders like depression and anxiety, schizophrenia, insomnia, Huntington’s, epilepsies, Alzheimer’s and Parkinson’s diseases. The Company is involved in the development of new and improved drugs for the treatment of psychiatric and neurological disorders. H. Lundbeck A/S is headquartered in Copenhagen, Denmark. “
Shares of H. Lundbeck A/S- (OTCMKTS HLUYY) opened at $51.99 on Friday. H. Lundbeck A/S- has a 52-week low of $40.70 and a 52-week high of $66.67. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.13 and a current ratio of 1.36. The stock has a market capitalization of $10,347.51, a P/E ratio of 26.94, a price-to-earnings-growth ratio of 1.36 and a beta of 0.17.
About H. Lundbeck A/S-
H Lundbeck A/S is a Denmark-based company active in the pharmaceuticals industry. It is engaged in the research, development, manufacture and marketing of pharmaceuticals for the treatment of brain disorders, such as Alzheimer’s disease, Bipolar disorder, depression, epilepsy, Huntington’s disease, Parkinson’s disease and schizophrenia.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for H. Lundbeck A/S- Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S- and related companies with MarketBeat.com's FREE daily email newsletter.